Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 397

1.

Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features.

Svahn J, Petiot P, Antoine JC, Vial C, Delmont E, Viala K, Steck AJ, Magot A, Cauquil C, Zarea A, Echaniz-Laguna A, Iancu Ferfoglia R, Gueguen A, Magy L, Léger JM, Kuntzer T, Ferraud K, Lacour A, Camdessanché JP; Francophone anti-MAG cohort Group.

J Neurol Neurosurg Psychiatry. 2017 Oct 25. pii: jnnp-2017-316715. doi: 10.1136/jnnp-2017-316715. [Epub ahead of print]

PMID:
29070644
2.

Muscle, neuromuscular junction and peripheral nerve diseases.

Léger JM.

Curr Opin Neurol. 2017 Oct;30(5):447-448. doi: 10.1097/WCO.0000000000000485. No abstract available.

PMID:
28731862
3.

Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial.

Merkies ISJ, Lawo JP, Edelman JM, De Bleecker JL, Sommer C, Robberecht W, Saarela M, Kamienowski J, Stelmasiak Z, Mielke O, Tackenberg B, Léger JM; PRIMA trial investigators.

J Peripher Nerv Syst. 2017 Jun;22(2):149-152. doi: 10.1111/jns.12204. No abstract available.

PMID:
28594116
4.

Editorial: introducing the new Co-Editors-in-Chief of Current Opinion in Neurology.

Eidelberg D, Léger JM.

Curr Opin Neurol. 2017 Jun;30(3):207. doi: 10.1097/WCO.0000000000000459. No abstract available.

PMID:
28402992
5.

Foreword.

Léger JM.

Rev Neurol (Paris). 2016 Dec;172(12):766. doi: 10.1016/j.neurol.2016.11.002. No abstract available.

PMID:
27919330
6.

Exerting Capacity.

Leger JM, Phillips CA.

West J Nurs Res. 2017 May;39(5):660-673. doi: 10.1177/0193945916664707. Epub 2016 Aug 17.

PMID:
27534423
7.

High dose subcutaneous immunoglobulin for idiopathic inflammatory myopathies and dysimmune peripheral chronic neuropathies treatment: observational study of quality of life and tolerance.

Hachulla E, Benveniste O, Hamidou M, Mouthon L, Schleinitz N, Lozeron P, Léger JM, Vial C, Viala K.

Int J Neurosci. 2017 Jun;127(6):516-523. doi: 10.1080/00207454.2016.1204544. Epub 2016 Jul 14.

PMID:
27412148
8.

Too Often Forgotten: Passive Transfer of Antibodies.

Thibault V, Pinte L, Vergez J, Leger JM, Liou A.

Clin Infect Dis. 2016 Sep 1;63(5):709-10. doi: 10.1093/cid/ciw337. Epub 2016 May 20. No abstract available.

PMID:
27208043
9.

[Beware of immunoglobulin's passive transfer when interpreting serological analyses!].

Pinte L, Vergez J, Liou A, Leger JM, Thibault V.

Presse Med. 2016 Jul-Aug;45(7-8 Pt 1):676-81. doi: 10.1016/j.lpm.2016.03.009. Epub 2016 Apr 28. French.

PMID:
27132942
10.

Long-term efficacy of rituximab in IgM anti-myelin-associated glycoprotein neuropathy: RIMAG follow-up study.

Iancu Ferfoglia R, Guimarães-Costa R, Viala K, Musset L, Neil J, Marin B, Léger JM.

J Peripher Nerv Syst. 2016 Mar;21(1):10-4. doi: 10.1111/jns.12156.

PMID:
26748872
11.

[Suicide headache].

Donnet A, Leger JM.

Presse Med. 2015 Nov;44(11):1170. doi: 10.1016/j.lpm.2015.11.001. French. No abstract available.

PMID:
26615084
12.

Immunotherapy in Peripheral Neuropathies.

Léger JM, Guimarães-Costa R, Muntean C.

Neurotherapeutics. 2016 Jan;13(1):96-107. doi: 10.1007/s13311-015-0401-7. Review.

13.

Versatile Method for Producing 2D and 3D Conductive Biomaterial Composites Using Sequential Chemical and Electrochemical Polymerization.

Severt SY, Ostrovsky-Snider NA, Leger JM, Murphy AR.

ACS Appl Mater Interfaces. 2015 Nov 18;7(45):25281-8. doi: 10.1021/acsami.5b07332. Epub 2015 Nov 6.

PMID:
26544990
14.

Amyotrophic lateral sclerosis, channelopathies and peripheral neuropathies: current status and new perspectives.

Léger JM.

Curr Opin Neurol. 2015 Oct;28(5):453-4. doi: 10.1097/WCO.0000000000000247. No abstract available.

PMID:
26356409
15.

Non HCV-related infectious cryoglobulinemia vasculitis: Results from the French nationwide CryoVas survey and systematic review of the literature.

Terrier B, Marie I, Lacraz A, Belenotti P, Bonnet F, Chiche L, Graffin B, Hot A, Kahn JE, Michel C, Quemeneur T, de Saint-Martin L, Hermine O, Léger JM, Mariette X, Senet P, Plaisier E, Cacoub P.

J Autoimmun. 2015 Dec;65:74-81. doi: 10.1016/j.jaut.2015.08.008. Epub 2015 Aug 29. Review.

PMID:
26320984
16.

Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN.

Zaidan M, Terrier B, Pozdzik A, Frouget T, Rioux-Leclercq N, Combe C, Lepreux S, Hummel A, Noël LH, Marie I, Legallicier B, François A, Huart A, Launay D, Kaplanski G, Bridoux F, Vanhille P, Makdassi R, Augusto JF, Rouvier P, Karras A, Jouanneau C, Verpont MC, Callard P, Carrat F, Hermine O, Léger JM, Mariette X, Senet P, Saadoun D, Ronco P, Brochériou I, Cacoub P, Plaisier E; CryoVas study group.

J Am Soc Nephrol. 2016 Apr;27(4):1213-24. doi: 10.1681/ASN.2015020114. Epub 2015 Aug 10.

17.

Long-term outcome of infliximab in severe chronic and refractory systemic sarcoidosis: a report of 16 cases.

Chapelon-Abric C, Saadoun D, Biard L, Sene D, Resche-Rigon M, Hervier B, Costedoat-Chalumeau N, Drier A, Leger JM, Cacoub P.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4):509-15. Epub 2015 Jun 29.

PMID:
26120779
18.

Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar.

Draak TH, Pruppers MH, van Nes SI, Vanhoutte EK, Bakkers M, Gorson KC, Van der Pol WL, Lewis RA, Notermans NC, Nobile-Orazio E, Léger JM, Van den Bergh PY, Lauria G, Bril V, Katzberg H, Lunn MP, Pouget J, van der Kooi AJ, van den Berg LH, van Doorn PA, Cornblath DR, Hahn AF, Faber CG, Merkies IS; PeriNomS study group.

J Peripher Nerv Syst. 2015 Sep;20(3):269-76. doi: 10.1111/jns.12126.

PMID:
26115516
19.

Outcome measures in MMN revisited: further improvement needed.

Pruppers MH, Draak TH, Vanhoutte EK, Van der Pol WL, Gorson KC, Léger JM, Nobile-Orazio E, Lewis RA, van den Berg LH, Faber CG, Merkies IS; PeriNomS study group.

J Peripher Nerv Syst. 2015 Sep;20(3):306-18. doi: 10.1111/jns.12124.

PMID:
26115442
20.

Impairment measures versus inflammatory RODS in GBS and CIDP: a responsiveness comparison.

Vanhoutte EK, Draak TH, Gorson KC, van Nes SI, Hoeijmakers JG, Van der Pol WL, Notermans NC, Lewis RA, Nobile-Orazio E, Léger JM, Van den Bergh PY, Lauria G, Bril V, Katzberg H, Lunn MP, Pouget J, van der Kooi AJ, Hahn AF, van Doorn PA, Cornblath DR, van den Berg LH, Faber CG, Merkies IS; PeriNomS Study Group.

J Peripher Nerv Syst. 2015 Sep;20(3):289-95. doi: 10.1111/jns.12118.

PMID:
26114893
21.

Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses.

Draak TH, Vanhoutte EK, van Nes SI, Gorson KC, Van der Pol WL, Notermans NC, Nobile-Orazio E, Lewis RA, Léger JM, Van den Bergh PY, Lauria G, Bril V, Katzberg H, Lunn MP, Pouget J, van der Kooi AJ, Hahn AF, van den Berg LH, van Doorn PA, Cornblath DR, Faber CG, Merkies IS; PeriNomS Study Group.

J Peripher Nerv Syst. 2015 Sep;20(3):277-88. doi: 10.1111/jns.12127.

PMID:
26110493
22.

[American Academy of Neurology, Washington, 18-25 April 2015].

Sibon I, de Toffol B, Azulay JP, Sellal F, Thomas-Antérion C, Léger JM, Pierrot-Deseilligny C.

Rev Neurol (Paris). 2015 Jun-Jul;171(6-7):581-601. doi: 10.1016/j.neurol.2015.04.005. Epub 2015 May 23. French.

PMID:
26005122
23.

The pathogenesis of multifocal motor neuropathy and an update on current management options.

Léger JM, Guimarães-Costa R, Iancu Ferfoglia R.

Ther Adv Neurol Disord. 2015 May;8(3):109-22. doi: 10.1177/1756285615575269. Review.

24.

Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy.

Umapathi T, Hughes RA, Nobile-Orazio E, Léger JM.

Cochrane Database Syst Rev. 2015 Mar 4;(3):CD003217. doi: 10.1002/14651858.CD003217.pub5. Review.

25.

Immunoglobulin (Ig) in multifocal motor neuropathy (MMN): update on evidence for Ig treatment in MMN.

Léger JM.

Clin Exp Immunol. 2014 Dec;178 Suppl 1:42-4. doi: 10.1111/cei.12505. No abstract available.

26.

[Foreword. 6th meeting of the French Peripheral Nerve Society].

Leger JM.

Rev Neurol (Paris). 2014 Dec;170(12):818. doi: 10.1016/j.neurol.2014.11.003. French. No abstract available.

PMID:
25487773
27.

Changing outcome in inflammatory neuropathies: Rasch-comparative responsiveness.

Draak TH, Vanhoutte EK, van Nes SI, Gorson KC, Van der Pol WL, Notermans NC, Nobile-Orazio E, Léger JM, Van den Bergh PY, Lauria G, Bril V, Katzberg H, Lunn MP, Pouget J, van der Kooi AJ, Hahn AF, Doorn PA, Cornblath DR, van den Berg LH, Faber CG, Merkies IS; PeriNomS Study Group.

Neurology. 2014 Dec 2;83(23):2124-32. doi: 10.1212/WNL.0000000000001044. Epub 2014 Nov 5.

PMID:
25378677
28.

Segmental somatosensory-evoked potentials as a diagnostic tool in chronic inflammatory demyelinating polyneuropathies, and other sensory neuropathies.

Koutlidis RM, Ayrignac X, Pradat PF, Le Forestier N, Léger JM, Salachas F, Maisonobe T, Fournier E, Viala K.

Neurophysiol Clin. 2014 Sep;44(3):267-80. doi: 10.1016/j.neucli.2014.08.006. Epub 2014 Aug 23.

PMID:
25240560
29.

Challenges in the treatment of chronic inflammatory demyelinating polyradiculoneuropathy.

Guimarães-Costa R, Iancu Ferfoglia R, Viala K, Léger JM.

Rev Neurol (Paris). 2014 Oct;170(10):595-601. doi: 10.1016/j.neurol.2014.06.002. Epub 2014 Sep 4.

PMID:
25200479
30.

[American Academy of Neurology, Philadelphia, 26 April-3 May, 2014].

Durif F, Sibon I, de Toffol B, Sellal F, Thomas-Anterion C, Léger JM, Pierrot-Deseilligny C.

Rev Neurol (Paris). 2014 Jun-Jul;170(6-7):471-86. doi: 10.1016/j.neurol.2014.05.001. Epub 2014 May 28. French. No abstract available.

PMID:
24880187
31.

[Amyotrophic lateral sclerosis: new concept and strategies for a heteregeneous entity].

Pradat PF, Léger JM.

Presse Med. 2014 May;43(5):536-7. doi: 10.1016/j.lpm.2014.04.004. French. No abstract available.

PMID:
24842791
32.

α-Halogenoacetanilides as hydrogen-bonding organocatalysts that activate carbonyl bonds: fluorine versus chlorine and bromine.

Koeller S, Thomas C, Peruch F, Deffieux A, Massip S, Léger JM, Desvergne JP, Milet A, Bibal B.

Chemistry. 2014 Mar 3;20(10):2849-59. doi: 10.1002/chem.201303662. Epub 2014 Feb 12.

PMID:
24519659
33.

Predictors of early relapse in patients with non-infectious mixed cryoglobulinemia vasculitis: results from the French nationwide CryoVas survey.

Terrier B, Marie I, Launay D, Lacraz A, Belenotti P, de Saint-Martin L, Quemeneur T, Huart A, Bonnet F, Le Guenno G, Kahn JE, Hinschberger O, Rullier P, Diot E, Lazaro E, Bridoux F, Zénone T, Carrat F, Hermine O, Léger JM, Mariette X, Senet P, Plaisier E, Cacoub P.

Autoimmun Rev. 2014 Jun;13(6):630-4. doi: 10.1016/j.autrev.2013.11.006. Epub 2014 Jan 10. Review.

PMID:
24418300
34.

An overview of the use of music therapy in the context of Alzheimer's disease: a report of a French expert group.

Guetin S, Charras K, Berard A, Arbus C, Berthelon P, Blanc F, Blayac JP, Bonte F, Bouceffa JP, Clement S, Ducourneau G, Gzil F, Laeng N, Lecourt E, Ledoux S, Platel H, Thomas-Anterion C, Touchon J, Vrait FX, Leger JM.

Dementia (London). 2013 Sep;12(5):619-34. doi: 10.1177/1471301212438290. Epub 2012 Mar 28. Review.

PMID:
24337333
35.

Immunotherapy-based regimen in anti-MAG neuropathy: results in 45 patients.

Hospital MA, Viala K, Dragomir S, Levy V, Cohen-Aubart F, Neil J, Musset L, Choquet S, Leger JM, Leblond V.

Haematologica. 2013 Dec;98(12):e155-7. doi: 10.3324/haematol.2013.087213. No abstract available.

36.

[5th Meeting of the Francophone Society of Peripheral Nerves / 5th Days of the Francophone Society of Peripheral Nerves: Foreword].

Léger JM.

Rev Neurol (Paris). 2013 Dec;169(12):970. doi: 10.1016/j.neurol.2013.10.007. French. No abstract available.

PMID:
24321487
37.

Chronic inflammatory demyelinating polyradiculoneuropathy: search for factors associated with treatment dependence or successful withdrawal.

Rabin M, Mutlu G, Stojkovic T, Maisonobe T, Lenglet T, Fournier E, Bouche P, Léger JM, Viala K.

J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):901-6. doi: 10.1136/jnnp-2013-306105. Epub 2013 Dec 5.

PMID:
24309269
38.

Characterizing ion profiles in dynamic junction light-emitting electrochemical cells.

Shoji TD, Zhu Z, Leger JM.

ACS Appl Mater Interfaces. 2013 Nov 27;5(22):11509-14. doi: 10.1021/am403805j. Epub 2013 Nov 11.

PMID:
24175736
39.

Meeting report: 2013 Peripheral Nerve Society Biennial Meeting, Saint-Malo, France, June 29-July 3, 2013.

Nobile-Orazio E, Léger JM, Lewis RA, Bolino A, Shy ME, Cornblath DR.

J Peripher Nerv Syst. 2013 Sep;18(3):197-8. doi: 10.1111/jns5.12041. No abstract available.

PMID:
24028187
40.

Editorial. Neuromuscular diseases.

Léger JM.

Curr Opin Neurol. 2013 Oct;26(5):457-8. doi: 10.1097/WCO.0b013e3283650824. No abstract available.

PMID:
24005262
41.

Multifocal motor neuropathy.

Guimarães-Costa R, Bombelli F, Léger JM.

Curr Opin Neurol. 2013 Oct;26(5):503-9. doi: 10.1097/WCO.0b013e328364caca. Review.

PMID:
23995271
42.

Efficient metal-free synthesis of various pyrido[2',1':2,3]imidazo- [4,5-b]quinolines.

Arnould M, Hiebel MA, Massip S, Léger JM, Jarry C, Berteina-Raboin S, Guillaumet G.

Chemistry. 2013 Sep 9;19(37):12249-53. doi: 10.1002/chem.201300961. Epub 2013 Aug 16.

PMID:
23955568
43.

Sensitivity and predictive value of anti-GM1/galactocerebroside IgM antibodies in multifocal motor neuropathy.

Nobile-Orazio E, Giannotta C, Musset L, Messina P, Léger JM.

J Neurol Neurosurg Psychiatry. 2014 Jul;85(7):754-8. doi: 10.1136/jnnp-2013-305755. Epub 2013 Aug 1.

PMID:
23907602
44.

Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study).

Léger JM, De Bleecker JL, Sommer C, Robberecht W, Saarela M, Kamienowski J, Stelmasiak Z, Mielke O, Tackenberg B, Shebl A, Bauhofer A, Zenker O, Merkies IS; PRIMA study investigators.

J Peripher Nerv Syst. 2013 Jun;18(2):130-40. doi: 10.1111/jns5.12017.

45.

Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathy.

Léger JM, Viala K, Nicolas G, Créange A, Vallat JM, Pouget J, Clavelou P, Vial C, Steck A, Musset L, Marin B; RIMAG Study Group (France and Switzerland).

Neurology. 2013 Jun 11;80(24):2217-25. doi: 10.1212/WNL.0b013e318296e92b. Epub 2013 May 10.

46.

The discovery of the Guillain-Barré syndrome and related disorders.

Hughes R, Léger JM.

Presse Med. 2013 Jun;42(6 Pt 2):e177-9. doi: 10.1016/j.lpm.2013.03.005. Epub 2013 Apr 28. No abstract available.

PMID:
23628445
47.

Multifocal motor neuropathy.

Guimarães-Costa R, Bombelli F, Léger JM.

Presse Med. 2013 Jun;42(6 Pt 2):e217-24. doi: 10.1016/j.lpm.2013.01.057. Epub 2013 Apr 25. Review.

PMID:
23623583
48.

[American Academy of Neurology, San Diego, 16-23 March 2013].

de Toffol B, Benatru I, Sibon I, Sellal F, Thomas-Anterion C, Léger JM, Pierrot-Deseilligny C.

Rev Neurol (Paris). 2013 May;169(5):442-56. doi: 10.1016/j.neurol.2013.03.007. Epub 2013 Apr 18. French. No abstract available.

PMID:
23602497
49.

[Rare diseases in neurology].

Léger JM.

Rev Neurol (Paris). 2013 Feb;169 Suppl 1:S1. doi: 10.1016/S0035-3787(13)70051-1. French. No abstract available.

PMID:
23452764
50.

[Address from the previous President, January 17, 2013].

Léger JM.

Rev Neurol (Paris). 2013 Mar;169(3):214-5. doi: 10.1016/j.neurol.2013.01.001. Epub 2013 Feb 28. French. No abstract available.

PMID:
23453275

Supplemental Content

Loading ...
Support Center